Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Intercede director PCA raises stake

(Sharecast News) - Intercede Group non-executive director Tina Whitley's husband, Colin Aldridge, acquired 20,718 ordinary shares in the AIM-listed cybersecurity software firm. Aldridge purchased the shares on Monday at an average price of 96.50p each, for a total value of £20,034.

Following the transaction, Aldridge has a shareholding of 40,135 ordinary Intercede shares, representing approximately 0.07% of the company's total voting rights.

As of 1610 GMT, Intercede shares were down 0.2% at 99.98p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Experian (EXPN) Director name: Lee,Esther Amount purchased: 3,206 @ $41.93 Value: $110,849.82

Jpmorgan Global Core Real Assets Limited (JARA) Director name: Russell,Chris Amount purchased: 95,000 @ 68.00p Value: £64,600.00

Keywords Studios (KWS) Director name: Robert,Don Amount purchased: 3,400 @ 1,631.00p Value: £55,454.00

Mulberry Group (MUL) Director name: Andretta,Thierry Amount purchased: 12,000 @ 120.00p Value: £14,400.00

Schroder European Real Estate Investment Trust (SERE) Director name: Beddy,Mark Amount purchased: 10,000 @ 69.49p Value: £6,949.22

B.p. Marsh & Partners (BPM) Director name: Carter,Nicholas Hugh Amount purchased: 474 @ 424.00p Value: £2,009.76

Grainger (GRI) Director name: Hudson ,Robert Amount purchased: 114 @ 259.00p Value: £295.26

Grainger (GRI) Director name: Gordon,Helen Amount purchased: 114 @ 259.00p Value: £295.26

Dp Eurasia N.v. (di) (DPEU) Director name: Bhartia,Shyam Sunder Amount purchased: 27,725 @ 0.94p Value: £259.58

Judges Scientific (JDG) Director name: Lavelle,Mark Amount purchased: 2 @ 9,615.00p Value: £192.30

Judges Scientific (JDG) Director name: Ormsby,Bradley Leonard Amount purchased: 2 @ 9,615.00p Value: £192.30

Judges Scientific (JDG) Director name: Prestidge,Tim Amount purchased: 2 @ 9,615.00p Value: £192.30

Judges Scientific (JDG) Director name: Cicurel,David Amount purchased: 2 @ 9,615.00p Value: £192.30

Avon Protection (AVON) Director name: Ingrey-Counter,Miles Amount purchased: 16 @ 982.00p Value: £157.12

Avon Protection (AVON) Director name: Sclater,Jos Amount purchased: 16 @ 982.00p Value: £157.12

Avon Protection (AVON) Director name: Cashin,Rich Amount purchased: 15 @ 982.00p Value: £147.30

Rathbones Group (RAT) Director name: Stockton,Paul Amount purchased: 9 @ 1,610.00p Value: £144.90

Top Director Sells

Pendragon (PDG) Director name: Berman,William Amount sold: 14,100,093 @ 36.35p Value: £5,125,383.79

Pendragon (PDG) Director name: Willis,Mark Simon Amount sold: 7,755,049 @ 36.35p Value: £2,818,960.30

Pendragon (PDG) Director name: Berman,William Amount sold: 4,203,103 @ 31.90p Value: £1,340,789.88

Pendragon (PDG) Director name: Willis,Mark Simon Amount sold: 2,311,707 @ 31.90p Value: £737,434.55

Safestore Holdings (SAFE) Director name: Vecchioli,Frederic Amount sold: 48,436 @ 792.15p Value: £383,685.78

Safestore Holdings (SAFE) Director name: Jones,Andy Amount sold: 34,510 @ 792.15p Value: £273,370.97

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.